Reckitt Benckiser has issued a voluntary recall for Mead Johnson Nutrition brand's baby formula powder. The U.S. Food and Drug Administration (US FDA) said that the health and nutrition firm decided to recall some batches of the said product due to possible bacterial contamination.
As per CNBC, the affected infant formula is being sold in the market as Nutramigen Powder. This infant formula is specially made for babies allergic to cow's milk. The recalled batches were produced in June and distributed to stores in the summer.
Recalled Batches of Nutramigen Powder
Reckitt Benckiser said that so far, it has not received any reports of illnesses or adverse effects related to the recalled Nutramigen Powder. However, the company is urging customers who have bought the milk formula to check the can to see if what they purchased is included in the batches that may have been contaminated.
The company said that the affected products have these batch numbers and their corresponding can sizes: ZL3FHG, 12.6 oz cans, ZL3FMH, 12.6 oz cans, ZL3FPE, 12.6 oz cans, ZL3FQD, 12.6 oz cans, ZL3FRW, 19.8 oz cans, and ZL3FXJ, 12.6 oz cans.
Adverse Effects of Bacterial Infection
Fox Business says the total number of the affected Nutramigen infant powder is about 675,030 cans. The FDA warned on Sunday, Dec. 31, that they may be contaminated with Cronobacter sakazakii.
The National Food Administration further said that the milk formula was made at a production facility in Michigan. The bacteria in the product potentially cause severe infections such as meningitis and sepsis. The FDA listed jaundice, irritability, temperature change, poor feeding, trouble breathing, and unusual movements as the common symptoms of the infection.
Meanwhile, the announcement stressed, "No other U.S. distributed Nutramigen batches or other Reckitt products are impacted."
Photo by: Reckltt Press Release


Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 



